journal article·2025-01

An “All‐in‐One” Strategy to Reconstruct Temporomandibular Joint Osteoarthritic Microenvironment Using γ‐Fe2O3@TA@ALN Nanoparticles

Xiao Cen, Junjie Deng, Xuefeng Pan, Rufang Wei, Zhimao Huang, Rong Tang, Shengkai Lu, Rong Wang, Zhihe Zhao, Xinqi Huang

Small· Volume 21· Issue 2
Publisher page

Abstract

Abstract Current clinical strategies for the treatment of temporomandibular joint osteoarthritis (TMJOA) primarily target cartilage biology, overlooking the synergetic effect of various cells and inorganic components in shaping the arthritic microenvironment, thereby impeding the effectiveness of existing therapeutic options for TMJOA. Here, γ‐Fe2O3@TA@ALN magnetic nanoparticles (γ‐Fe2O3@TA@ALN MNPs) composed of γ‐Fe2O3, tannic acid (TA), and alendronate sodium (ALN) are engineered to reconstruct the osteoarthritic microenvironment and mitigate TMJOA progression. γ‐Fe2O3@TA@ALN MNPs can promote chondrocytes’ proliferation, facilitate chondrogenesis and anisotropic organization, enhance lubrication and reduce cartilage wear, and encourage cell movement. Magnetic‐responsive γ‐Fe2O3@TA@ALN MNPs also exhibit pH sensitivity, which undergoes decomposition within acidic environment to release ALN on demand. Under a 0.2 T static magnetic field, γ‐Fe2O3@TA@ALN MNPs accelerate the synthesis of cartilage‐specific proteins, and suppress catabolic‐related genes expression and reactive oxygen species generation, affording additional protection to TMJ cartilage. In TMJOA mouse models, articular injection of γ‐Fe2O3@TA@ALN MNPs effectively alleviates cartilage degeneration and subchondral bone loss in short and long terms, offering promising avenues for the development of therapeutic interventions for TMJOA.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Temporomandibular Joint Disorders · Periodontal Regeneration and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu Sichuan 610041 China

Laboratory of Advanced Theranostic Materials and Technology Ningbo Institute of Materials Technology and Engineering Chinese Academy of Sciences Ningbo Zhejiang 315201 P. R. China

Zhejiang International Scientific and Technological Cooperative Base of Biomedical Materials and Technology Ningbo Cixi Institute of Biomedical Engineering Ningbo Zhejiang 315300 P. R. China

Cixi Biomedical Research Institute Wenzhou Medical University Ningbo Zhejiang 325035 P. R. China

Funding

National Natural Science Foundation of China · Youth Innovation Promotion Association of the Chinese Academy of Sciences

References (77)

Show source-provided references
1. National Institute of Dental and Craniofacial Research2018 https://www.nidcr.nih.gov/research/data‐statistics/facial‐pain/prevalence(accessed: July 2018).
2. 10.1111/jcmm.1651410.1111/jcmm.16514 ↗
3. 10.1177/002203451665374310.1177/0022034516653743 ↗
4. 10.1016/j.bone.2020.11558410.1016/j.bone.2020.115584 ↗
5. 10.1177/002203451557477010.1177/0022034515574770 ↗
6. 10.1016/j.jds.2023.04.00210.1016/j.jds.2023.04.002 ↗
7. 10.1016/j.joms.2016.08.01710.1016/j.joms.2016.08.017 ↗
8. 10.1007/s00784-021-04241-810.1007/s00784-021-04241-8 ↗
9. 10.1021/jacs.2c0270610.1021/jacs.2c02706 ↗
10. 10.1021/jacs.0c0730910.1021/jacs.0c07309 ↗
11. 10.1126/sciadv.abl643210.1126/sciadv.abl6432 ↗
12. 10.1002/adma.20190453510.1002/adma.201904535 ↗
13. 10.1186/s12951-022-01277-010.1186/s12951-022-01277-0 ↗
14. 10.3389/fchem.2021.62905410.3389/fchem.2021.629054 ↗
15. 10.3390/nano1205075710.3390/nano12050757 ↗
16. 10.1186/1556-276X-7-14410.1186/1556-276X-7-144 ↗
17. 10.1186/s12951-022-01595-310.1186/s12951-022-01595-3 ↗
18. 10.3390/pharmaceutics1405093710.3390/pharmaceutics14050937 ↗
19. 10.3390/ijms1908223010.3390/ijms19082230 ↗
20. 10.1002/adhm.20170093210.1002/adhm.201700932 ↗
21. Halder J. · J. Drug Targeting · 2022 · 30 · 1055
22. 10.1073/pnas.210236311910.1073/pnas.2102363119 ↗
23. 10.2147/IJN.S38181510.2147/IJN.S381815 ↗
24. 10.1016/j.addr.2016.03.01210.1016/j.addr.2016.03.012 ↗
25. 10.1186/s13287-020-01885-310.1186/s13287-020-01885-3 ↗
26. 10.1002/art.3903010.1002/art.39030 ↗
27. 10.4252/wjsc.v14.i7.51310.4252/wjsc.v14.i7.513 ↗
28. 10.1177/0363546521100575410.1177/03635465211005754 ↗
29. 10.1016/j.biomaterials.2016.02.00410.1016/j.biomaterials.2016.02.004 ↗
30. 10.3390/antiox1006098510.3390/antiox10060985 ↗
31. 10.1016/j.joca.2017.07.02010.1016/j.joca.2017.07.020 ↗
32. 10.1016/j.jep.2024.11788710.1016/j.jep.2024.117887 ↗
33. 10.1016/j.progpolymsci.2018.08.00510.1016/j.progpolymsci.2018.08.005 ↗
34. 10.1002/anie.20131113610.1002/anie.201311136 ↗
35. 10.1002/adma.20160575410.1002/adma.201605754 ↗
36. 10.1136/ard.2008.08991210.1136/ard.2008.089912 ↗
37. 10.1002/art.2012410.1002/art.20124 ↗
38. 10.1038/s41413-021-00147-z10.1038/s41413-021-00147-z ↗
39. 10.1016/j.bone.2012.12.04410.1016/j.bone.2012.12.044 ↗
40. 10.3390/biomedicines908101710.3390/biomedicines9081017 ↗
41. 10.2478/intox-2013-001910.2478/intox-2013-0019 ↗
42. 10.1021/jp500074g10.1021/jp500074g ↗
43. 10.1002/anie.20160366310.1002/anie.201603663 ↗
44. 10.1021/acs.macromol.5b0032710.1021/acs.macromol.5b00327 ↗
45. 10.1016/j.colsurfb.2012.10.06710.1016/j.colsurfb.2012.10.067 ↗
46. 10.2147/IJN.S26963010.2147/IJN.S269630 ↗
47. 10.3390/colloids701002310.3390/colloids7010023 ↗
48. 10.31083/j.fbl281027410.31083/j.fbl2810274 ↗
49. 10.1016/j.ydbio.2017.04.00610.1016/j.ydbio.2017.04.006 ↗
50. 10.1126/sciadv.ade464510.1126/sciadv.ade4645 ↗
51. 10.1016/j.joca.2006.09.01010.1016/j.joca.2006.09.010 ↗
52. 10.1016/S0736-0266(00)00040-110.1016/S0736-0266(00)00040-1 ↗
53. 10.1016/j.biomaterials.2003.10.02910.1016/j.biomaterials.2003.10.029 ↗
54. 10.1016/j.carbpol.2024.12182110.1016/j.carbpol.2024.121821 ↗
55. 10.1016/j.jconrel.2020.09.00810.1016/j.jconrel.2020.09.008 ↗
56. 10.1016/j.phrs.2024.10714110.1016/j.phrs.2024.107141 ↗
57. 10.1021/acsami.2c2026510.1021/acsami.2c20265 ↗
58. 10.1038/nrm189010.1038/nrm1890 ↗
59. 10.1073/pnas.071170410510.1073/pnas.0711704105 ↗
60. 10.1016/j.nano.2013.06.01410.1016/j.nano.2013.06.014 ↗
61. 10.1002/anie.20210087310.1002/anie.202100873 ↗
62. 10.1186/s11658-023-00489-y10.1186/s11658-023-00489-y ↗
63. 10.1002/adhm.20220319510.1002/adhm.202203195 ↗
64. 10.1093/rheumatology/41.5.48410.1093/rheumatology/41.5.484 ↗
65. 10.1177/0022034521103724810.1177/00220345211037248 ↗
66. 10.1177/002203452090171010.1177/0022034520901710 ↗
67. 10.1038/ng0697-17410.1038/ng0697-174 ↗
68. 10.1074/jbc.275.15.1073810.1074/jbc.275.15.10738 ↗
69. 10.1186/ar38010.1186/ar380 ↗
70. 10.1038/sj.cr.729010610.1038/sj.cr.7290106 ↗
71. 10.1136/ard.61.7.59110.1136/ard.61.7.591 ↗
72. 10.1038/srep3008510.1038/srep30085 ↗
73. 10.1177/0022034523119844810.1177/00220345231198448 ↗
74. 10.1186/s13287-021-02501-810.1186/s13287-021-02501-8 ↗
75. 10.1111/odi.1433110.1111/odi.14331 ↗
76. Xu X. · Bioact. Mater. · 2022 · 25 · 701
77. 10.1038/nprot.2010.8110.1038/nprot.2010.81 ↗